Literature DB >> 30123930

Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohort.

Xin-Yao Wu1, Min Yang2, Yue-Sheng Xie3, Wei-Guo Xiao4, Jin Lin5, Bin Zhou6, Xin Guan7, Cai-Nan Luo8, Nan Che9, Xing-Zhen Liu10, Chao Wang11, Jia-Lin Teng1, Xiao-Bing Cheng1, Jun-Na Ye1, Yu-Tong Su1, Hui Shi1, Yu-Feng Yin1, Meng-Ru Liu1, Yue Sun1, Qiong-Yi Hu1, Zhuo-Chao Zhou1, Hui-Hui Chi1, Yi Liu2, Xiao Zhang3, Jin-Wei Chen7, Miao-Jia Zhang9, Dong-Bao Zhao10, Cheng-de Yang12, Li-Jun Wu13, Hong-Lei Liu14.   

Abstract

To estimate the mortality and describe the causes of death in a large multicenter cohort of hospitalized patients with SLE in China. This was a retrospective study of a nationwide SLE cohort (10 centers, 29,510 hospitalized patients) from 2005 to 2014 in China. Standardized mortality ratios (SMRs) were calculated for all death and were stratified by sex and age. Chi-square test was used to determine whether the major causes of death vary in age, sex, duration of SLE, disease activity, or medications. Comparison between dead patients and survival controls was used to identify the risk factors for mortality. Logistic regression analysis was used to evaluate the risk factors for mortality. A total of 360 patients died during the study period, accounting for 1.22%. The overall SMR was 2.13 (95% CI 1.96, 2.30), with a particularly high SMR seen in subgroups characterized by younger age. Infection (65.8%) was the most common cause of death, followed by lupus nephritis (48.6%), hematological abnormality (18.1%), neuropsychiatric lupus/NPSLE (15.8%), and interstitial pneumonia (13.1%). Cardiovascular disease and malignancy contributed little to the causes of death. Infection, in particular severe pulmonary infection, emerged as the foremost risk factor for mortality, followed by lupus encephalopathy. However, lupus nephritis and hematological abnormalities occurred more frequently in survival patients. SLE patients at a younger age of diagnosis have a poorer prognosis. Infection dominated the causes of death in recent China. Ethnicity and medications might account for the differences in causes of death compared with western populations.

Entities:  

Keywords:  Cardiovascular disease; Cause of death; Infection; Standardized mortality ratio; Systemic lupus erythematosus

Mesh:

Year:  2018        PMID: 30123930     DOI: 10.1007/s10067-018-4259-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  16 in total

1.  Low dosage use of cyclophosphamide improves the survival of patients with systemic lupus erythematosus.

Authors:  Yoosuf Ali Ashraf Muhammad Hussenbocus; Ziyi Jin; Wenyou Pan; Lin Liu; Min Wu; Huaixia Hu; Xiang Ding; Hua Wei; Yaohong Zou; Xian Qian; Meimei Wang; Jian Wu; Juan Tao; Jun Tan; Zhanyun Da; Miaojia Zhang; Jing Li; Xuebing Feng; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2022-03-01       Impact factor: 2.980

2.  High risk of depression, anxiety, and an unfavorable complex comorbidity profile is associated with SLE: a nationwide patient-level study.

Authors:  Fruzsina Kósa; Péter Kunovszki; Judit Gimesi-Országh; Melinda Kedves; Melinda Szabó; Chetan S Karyekar; György Nagy
Journal:  Arthritis Res Ther       Date:  2022-05-19       Impact factor: 5.606

Review 3.  Management and outcomes in children with lupus nephritis in the developing countries.

Authors:  Priyanka Khandelwal; Srinivasavaradan Govindarajan; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2022-10-18       Impact factor: 3.651

4.  Creatinine clearance rate predicts prognosis of patients with systemic lupus erythematosus: a large retrospective cohort study.

Authors:  Jiahuan Ge; Ziyi Jin; Xuebing Feng; Wenyou Pan; Lin Liu; Min Wu; Huaixia Hu; Xiang Ding; Hua Wei; Yaohong Zou; Xian Qian; Meimei Wang; Jian Wu; Juan Tao; Jun Tan; Zhanyun Da; Miaojia Zhang; Jing Li; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2020-11-05       Impact factor: 2.980

5.  In-hospital mortality in patients with systemic lupus erythematosus: a study from Jordan 2002-2017.

Authors:  Marwan H Adwan; Ula Qasem; Khader N Mustafa
Journal:  Rheumatol Int       Date:  2020-03-07       Impact factor: 2.631

6.  Invasive mycoses in patients with connective tissue disease from Southern China: clinical features and associated factors.

Authors:  Minxi Lao; Zhongping Zhan; Fan Su; Hao Li; Zheng Yang; Haihong Chen; Liuqin Liang; Dongying Chen
Journal:  Arthritis Res Ther       Date:  2019-03-11       Impact factor: 5.156

Review 7.  Individualizing Therapy in Lupus Nephritis.

Authors:  Yu An; Haitao Zhang; Zhihong Liu
Journal:  Kidney Int Rep       Date:  2019-08-20

8.  Comparative proteomics analysis of plasma protein in patients with neuropsychiatric systemic lupus erythematosus.

Authors:  Chen Chen; Linyu Geng; Xue Xu; Wei Kong; Yayi Hou; Genhong Yao; Xuebing Feng; Huayong Zhang; Jun Liang
Journal:  Ann Transl Med       Date:  2020-05

9.  Mortality risk prediction in lupus patients complicated with invasive infection in the emergency department: LUPHAS score.

Authors:  Wanlong Wu; Jun Ma; Yuhong Zhou; Chao Tang; Feng Zhao; Fangfang Sun; Wenwen Xu; Jie Chen; Shuang Ye; Yi Chen
Journal:  Ther Adv Musculoskelet Dis       Date:  2019-11-05       Impact factor: 5.346

Review 10.  Global epidemiology of systemic lupus erythematosus.

Authors:  Megan R W Barber; Cristina Drenkard; Titilola Falasinnu; Alberta Hoi; Anselm Mak; Nien Yee Kow; Elisabet Svenungsson; Jonna Peterson; Ann E Clarke; Rosalind Ramsey-Goldman
Journal:  Nat Rev Rheumatol       Date:  2021-08-03       Impact factor: 32.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.